Pertussis: Clinical Trials

38 trials for Pertussis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 6 unknown, 1 not yet recruiting. 38 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 438Completed 31, Unknown 6, Not yet recruiting 1

Follow Pertussis: new trials by email Literature Review of Pertussis trials Research Report on Pertussis

Trials (filtered) newest first · largest first

All 38 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old
Maternal TdaP2gen vaccine, Infant Acellular Pertussis-containing Vaccine, Infant Whole-cell Pertussis-containing Vaccine - Pertussis, Diphtheria
Phase 4Not yet recruitingChiang Mai University3202026-05-262026-06-02
10-year Follow-up After a Single Dose Acellular Pertussis Vaccination
Pertagen® vaccine, Adacel® vaccine - Pertussis
Phase 4CompletedMahidol University902025-05-132026-10-08
Maternal Determinants of Infant Immunity to Pertussis
Triaxis® (Pertussis-containing vaccine), Vaxelis® (Pertussis-containing vaccine) - Vaccination; Infection, Maternal-Fetal Relations
Phase 4CompletedCentre Hospitalier Universitaire Saint Pierre2002023-09-122026-01-13
A Phase IV Study to Assess the Safety of EupentaTM Inj
Eupenta Inj. - Hepatitis B, Diphtheria
Phase 4UnknownLG Chem30002019-09-232019-08-14
Pertussis Vaccination in Pregnant Women
Boostrix administered during gestational diabetes screening, Boostrix administered in high volume obstetric clinic - Pertussis
Phase 4CompletedSt. Justine's Hospital9462019-06-012021-09-24
Optimising the Timing of Whooping Cough Immunisation in MUMs
Pertussis containing vaccine - Pregnancy Related, Immunization; Infection
Phase 4UnknownSt George's, University of London3542019-05-072021-03-18
Gambia Pertussis Study (GaPs)
Boostrix IPV infant acellular Pertussis, Boostrix IPV infant whole Pertussis, TT infant acellular Pertussis - Pertussis
Phase 4UnknownLondon School of Hygiene and Tropical Medicine6002019-01-232022-03-16
A Study Exploring Whooping Cough Protection in Children and Adults
Boostrix®-IPV combination vaccine - Pertussis
Phase 4CompletedUniversity of Oxford1222018-04-182021-01-08
Adacel® Booster Vaccination for CMI Assay Development
Adacel® - Pertussis
Phase 4CompletedDalhousie University102017-07-122020-09-10
Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand
Boostrix, Infanrix hexa, Quinvaxem - Pertussis
Phase 4CompletedUniversiteit Antwerpen3702015-04-012019-10-24
Pertussis and Meningitis C Concomitant Vaccination in Adolescents
Meningococcal vaccine, Pertussis containing vaccine - Pertussis, Meningitis
Phase 4CompletedPublic Health England4002013-09-012019-03-22
Tdap Vaccine in Post-Partum Women
Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed onto aluminum phosphate - Diphtheria, Pertussis
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)552012-10-262017-05-05
Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age
Meningococcal polysaccharide diphtheria toxoid conjugate, Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate - Meningitis, Meningococcal Infection
Phase 4CompletedSanofi Pasteur, a Sanofi Company13942012-07-012015-12-15
Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®), Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®) - Tetanus, Diphtheria
Phase 4CompletedSanofi Pasteur, a Sanofi Company4232012-06-012016-03-02
Pertussis (Tdap) Vaccination in Pregnancy
Pertussis vaccine - Pertussis, Pregnancy
Phase 4CompletedUniversiteit Antwerpen992012-02-012019-10-24
Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China
DTacP IPV//PRP~T combined vaccine: PENTAXIM® - Diphtheria, Tetanus
Phase 4CompletedSanofi Pasteur, a Sanofi Company9002011-12-012013-03-29
Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose
Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine, Tetanus and Diphtheria Toxoids Adsorbed For Adult Use - Tetanus, Diphtheria
Phase 4CompletedSanofi Pasteur, a Sanofi Company13302011-11-012022-04-28
Regulatory Post-Marketing Surveillance Study for TETRAXIM™
TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio - Diphtheria, Tetanus
Phase 4CompletedSanofi Pasteur, a Sanofi Company6002011-06-012022-03-28
Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination
Quinvaxem, Quinvaxem/Tritanrix - Diphtheria, Pertussis
Phase 4CompletedCrucell Holland BV4002011-05-012013-09-09
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed - Tetanus, Diphtheria
Phase 4CompletedSanofi13022011-03-012016-04-08

Showing 20 of 38. Sign in to see all of them.

Narrower conditions

Whooping Cough (38)  ·  Diphtheria (27)  ·  Tetanus (27)  ·  Haemophilus Infections (9)  ·  Poliomyelitis (8)  ·  Hepatitis B (5)  ·  Meningitis (3)  ·  Infections (2)  ·  Meningococcal Infections (2)  ·  Infant Death (1)  ·  Measles (1)  ·  Vaccine-Preventable Diseases (1)  ·  Virus Diseases (1)

Broader conditions

Bacterial Infections (38)  ·  Bacterial Infections and Mycoses (38)  ·  Bordetella Infections (38)  ·  Gram-Negative Bacterial Infections (38)  ·  Respiratory Tract Diseases (38)  ·  Respiratory Tract Infections (38)  ·  Infections (36)  ·  Actinomycetales Infections (27)  ·  Clostridium Infections (27)  ·  Corynebacterium Infections (27)  ·  Gram-Positive Bacterial Infections (27)  ·  Virus Diseases (13)  ·  Nervous System Diseases (11)  ·  Neuroinflammatory Diseases (11)  ·  Pasteurellaceae Infections (9)

Interventions

adacel (14)  ·  Tetanus Toxoid (11)  ·  Boostrix (5)  ·  Meningococcal Vaccines (3)  ·  Pentavac (3)  ·  Diphtheria-Tetanus Vaccine (2)  ·  Pertussis Vaccine (2)  ·  Diphtheria Toxoid (1)  ·  Diphtheria-Tetanus-acellular Pertussis Vaccines (1)  ·  HibTITER protein, Haemophilus influenzae (1)  ·  Measles Vaccine (1)  ·  Poliovirus Vaccine, Inactivated (1)  ·  Poliovirus Vaccine, Oral (1)  ·  Sodium Chloride (1)  ·  Vaccines (1)

Sponsors

Sanofi Pasteur, a Sanofi Company (11)  ·  Sanofi (6)  ·  Shantha Biotechnics Limited (3)  ·  Universiteit Antwerpen (2)  ·  Bandim Health Project (1)  ·  Centre Hospitalier Universitaire Saint Pierre (1)  ·  Chiang Mai University (1)  ·  Crucell Holland BV (1)  ·  Dalhousie University (1)  ·  LG Chem (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Mahidol University (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Norwegian Institute of Public Health (1)  ·  Public Health England (1)

Countries

United States (10)  ·  Canada (5)  ·  Thailand (5)  ·  India (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Philippines (2)  ·  South Korea (2)  ·  China (1)  ·  Finland (1)  ·  Germany (1)  ·  Guinea-Bissau (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Puerto Rico (1)

Top investigators

Raman Rao, MD (3)  ·  Beate Kampmann, MD, PhD (1)  ·  Caroline Quach, MD (1)  ·  Dr Dominic Kelly (1)  ·  Dr Marlies van Houten (1)  ·  Elke Leuridan, MD PhD (1)  ·  Elke Leuridan, MD, PhD (1)  ·  Eva Netterlid (1)  ·  Leif Gothefors, Prof. em. (1)  ·  Maria RZ Capeding, MD (1)  ·  Monique L MacFarlane Conrad, MSc (1)

Results publications

PMID 20616762, PMID 22115634, PMID 23077849, PMID 24176498, PMID 24835247, PMID 25008903, PMID 25230939, PMID 26057135, PMID 27142328, PMID 29438562, PMID 29573876, PMID 31301919, PMID 31418814, PMID 31945015, PMID 32331806, PMID 35135700, PMID 35575974, PMID 37080224, PMID 37285482, PMID 38752802, PMID 39066382, PMID 39385752, PMID 39951075, PMID 40154521, PMID 41122946, PMID 41519134

NIH funding

2008 (1)